Ledger.Open graph →
SEC Form D · filed November 6, 2020

MIRAGEN THERAPEUTICS, INC

Offering
$91.0M
Sold
$91.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOULDER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jeffrey S. Hatfield · Boulder, CODirectorJason A. Leverone · Boulder, COExecArlene M. Morris · Boulder, CODirectorJonathan Violin · Philadelphia, PAExecLee M. Rauch · Boulder, COExec · DirectorPeter E. Harwin · Boulder, CODirectorJames, Iii B. Mcginty · Terrell, TXDirectorMark Carhart · New York, NYDirectorAnthony B. Lennen · Indianapolis, INExecJoesph L. Turner · Boulder, CODirectorDiana A. Escolar · Boulder, COExecTomas E. Kiselak · Boulder, CODirectorAmy D. Glover · Indianapolis, INExecNull Assure Fund Management Ii · Salt Lake City, UTDirectorTomas N. Diaz Mathe · Irving, TXDirectorJoesph L. Turner · Boulder, CODirectorJonathan Violin · Philadelphia, PAExecLee M. Rauch · Boulder, COExec · DirectorDiana A. Escolar · Boulder, COExecPeter E. Harwin · Boulder, CODirectorTomas E. Kiselak · Boulder, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗